Dendritic cell immunotherapy for cancer: Application to low-grade lymphoma and multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dendritic cell immunotherapy for cancer: Application to low-grade lymphoma and multiple myeloma

Published:1999-10 Issue:5 Volume:77 Page:451-459
ISSN:0818-9641
Container-title:Immunology and Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

Hart DNJ¹,Hill GR¹

Affiliation:

1. Mater Medical Research Institute and Cancer Services, Mater Adult Hospital; South Brisbane Queensland Australia

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1440-1711.1999.00859.x/fullpdf

Reference99 articles.

1. Strategies for immunoprophylaxis and immunotherapy of papilloma viruses.;Frazer;Clin. Dermatol.,1997

2. Candidate vaccines for Epstein-Barr Virus.;Moss;BMJ,1998

3. HLA-DR1-restricted bcr-abl (b3a2)-specific CD4+ T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen-presenting cells exposed to b3a2 containing cell lysates.;Mannering;Blood,1997

4. T cell clones specific for p21 ras-derived peptides: Characterization of their fine specificity and HLA restriction.;Gedde-Dahl;Eur. J. Immunol.,1993

5. The labyrinthine ways of cancer immunotherapy - T cell, tumour cell encounter. ‘How do I lose thee? Let me count the ways?’;Ellem;Adv. Canc. Res.,1998

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Plasmacytoid and Myeloid Dendritic Cells in Breast Cancer Patients: A Pilot Study;Journal of Breast Cancer;2019

2. DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma;Journal of Immunotherapy;2017-11

3. Targeting the immune niche within the bone marrow microenvironment: The rise of immunotherapy in Multiple Myeloma;Current Cancer Drug Targets;2017-02-14

4. Immunotherapy in multiple myeloma;Translational Cancer Research;2017-02

5. Immunotherapy for Multiple Myeloma, Past, Present, and Future: Monoclonal Antibodies, Vaccines, and Cellular Therapies;Current Hematologic Malignancy Reports;2015-09-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3